01-Dec-2010 - Novartis will reduce its US General Medicines sales force by 1,400 employees next year in preparation for impending patent loss for key products.
08-Nov-2010 - Celanese has launched a new controlled-release EVA excipient and says developing enhanced formulations is key to a drugmaker’s competitive edge in today’s pharmaceutical market.
28-Oct-2010 - Drug industry demand for chemical intermediates and development projects has rebounded significantly in the last 12 months according to UK group Endeavour Specialty Chemicals.
20-Oct-2010 - Particle Sciences (PSI) becomes provider of Solumer drug delivery tech in deal with Israeli developer SoluBest.
19-Oct-2010 - Prosonix expects high demand for innovative particle processing technologies in the $24bn (€17bn) a-year respiratory pharmaceuticals market over the next few years.
18-Oct-2010 - Data from a study comparing an oral spray formulation of sildenafil citrate to Viagra has been presented by NovaDel Pharma.
13-Oct-2010 - IMS Health predicts that global drug sales will increase 5 to 7 per cent next year, driven by development of innovative pharmaceuticals and growth of emerging markets.
29-Sep-2010 - Venus Remedies is supplying docetaxel to Thailand after a compulsory license was issued to make the drug more affordable.
27-Sep-2010 - Stirling Products is in discussions with three large pharma interesting in accessing its HDA drug delivery platform.
23-Sep-2010 - India’s Sun Pharma has finally acquired a controlling stake in Israeli generics firm Taro Pharmaceutical Industries, significantly expanding its manufacturing capacity in North America.
23-Sep-2010 - Oracle is revising its lifecycle management package to streamline processes including scale-up to commercial production and QbD implementation.
15-Sep-2010 - Q Chip is using new funding to scale up its Q-Sphera technology for cGMP production of sustained release peptide and protein therapeutics.
14-Sep-2010 - Sanofi Pasteur has filed a sBLA with the FDA for an intradermal form of influenza vaccine Fluzone using a microinjection system.
08-Sep-2010 - GSK will work with Lonza on the development of a UK biomanufacturing plant as part of a new MAb manufacturing contract announced today.
08-Sep-2010 - Actavis is looking to enter the biosimilars sector through the proposed acquisition of a stake in Biopartners.
07-Sep-2010 - Indian drugmaker Cipla may invest in South Africa’s Cipla Medpro to boost manufacturing capacity and improve access to rapidly expanding African pharmaceutical markets.
06-Sep-2010 - Colorcon says proximity to emerging drug manufacturing markets was key driver for new Turkey technical service lab.
01-Sep-2010 - NanGenex is introducing GMP bench-top and pilot plant reactors to scale-up its process for the continuous production of nanostructured active ingredients.
31-Aug-2010 - Genzyme has rejected Sanofi-Aventis' $18.5bn (€14.5bn) takeover bid, describing it as offering no improvement in price on the previous proposal and failing “to establish a basis for engagement.”
31-Aug-2010 - Laboratory study shows succinyl-chitosan extended-release (XR) excipient could outperform commercially-available delivery technologies, says Spenser Pharmaceuticals.
26-Aug-2010 - Transdermal delivery of a broader range of therapeutics could be possible using microdevice fabrication technology Vyteris inked a deal to access.
19-Aug-2010 - Improving safety and efficacy coupled with drug industry desire for “stronger” patents will drive growth of the biologics sector over the next five years, according to new research.
16-Aug-2010 - Scolr Pharma reduces losses despite drop in revenue by cutting spending on product R&D and operations.
11-Aug-2010 - Elan puts plans to sell EDT delivery division on hold because market is not “conducive to an appropriate valuation.”
09-Aug-2010 - Respiratory formulations specialist Vectura has licensed two dry-formulation technologies to GSK, further strengthening its position in the $25bn (€19bn) asthma and COPD market.